Journal
CURRENT TOPICS IN MEDICINAL CHEMISTRY
Volume 19, Issue 15, Pages 1289-1304Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568026619666190618130008
Keywords
Microtubules; Antimitotic; Antitumour; Tubulin-colchicine binding site; Inhibitors; Antibody-drug conjugates; Degraders
Categories
Funding
- National Natural Science Foundation of China [U1204806]
- Henan Province Postdoctoral Science Foundation [1902001]
- Henan Medical Science and Technology Program [2018020601]
Ask authors/readers for more resources
Microtubules are essential for the mitotic division of cells and have been an attractive target for antitumour drugs due to the increased incidence of cancer and significant mitosis rate of tumour cells. In the past few years, tubulin-colchicine binding site, as one of the three binding pockets including taxol-, vinblastine- and colchicine-binding sites, has been focused on to design tubulin-destabilizing agents including inhibitors, antibody-drug conjugates and degradation agents. The present review is the first to cover a systemic and recent synopsis of tubulin-colchicine binding site agents. We believe that it would provide an increase in our understanding of receptor-ligand interaction pattern and consciousness of a series of challenges about tubulin target druggability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available